James Basta - 05 Jan 2026 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role: EVP, General Counsel
Signature: James Basta
Issuer symbol: NTLA
Transactions as of: 05 Jan 2026
Net transactions value: -$95,756
Form type: 4
Filing time: 07 Jan 2026, 16:05:11 UTC
Previous filing: 04 Mar 2025
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BASTA JAMES	EVP, General Counsel	C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE	James Basta	07 Jan 2026	0001792726

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NTLA	Common Stock	Sale	$95,756	-10,397	-9.3%	$9.21	101,528	05 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.